Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
29.84
-1.53 (-4.88%)
At close: Jun 16, 2025, 3:59 PM
29.81
-0.10%
After-hours: Jun 16, 2025, 07:55 PM EDT
-4.88% (1D)
| Bid | 29.37 |
| Market Cap | 3.6B |
| Revenue (ttm) | 8.93M |
| Net Income (ttm) | -369.22M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -9.95 |
| Forward PE | -7.26 |
| Analyst | Buy |
| Ask | 30.34 |
| Volume | 895,376 |
| Avg. Volume (20D) | 1,572,638 |
| Open | 31.29 |
| Previous Close | 31.37 |
| Day's Range | 29.81 - 31.65 |
| 52-Week Range | 21.51 - 56.00 |
| Beta | 0.95 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-18.65%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
3 months ago
+10.24%
Avidity Biosciences shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and anounced a $72 price target.
